cached image

Arvid Carlsson - Publications

Affiliations: 
University of Göteborg, Gothenburg, Västra Götalands län, Sweden 
Area:
Monoamine neurotransmission and pharmacology
Website:
http://www.nobelprize.org/nobel_prizes/medicine/laureates/2000/carlsson.html

265 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Tolboom N, Berendse HW, Leysen JE, Yaqub M, van Berckel BN, Schuit RC, Ponsen MM, Bakker E, Hoetjes NJ, Windhorst AD, Carlsson ML, Lammertsma AA, Carlsson A. The dopamine stabilizer (-)-OSU6162 occupies a subpopulation of striatal dopamine D2/D3 receptors: an [(11)C]raclopride PET study in healthy human subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 472-9. PMID 25248987 DOI: 10.1038/Npp.2014.195  0.39
2013 Jerlhag E, Steensland P, Fredriksson I, Feltmann K, Egecioglu E, Engel J, Steensland P, Fredriksson I, Feltmann K, Holst S, Franck J, Schilstrom B, Carlsson A, Colombo G, Naassila M, et al. S10 * EMERGING DRUGS FOR TREATING ALCOHOL USE DISORDERS: PRECLINICAL EVIDENCE Alcohol and Alcoholism. 48: i11-i12. DOI: 10.1093/Alcalc/Agt075  0.544
2012 Steensland P, Fredriksson I, Holst S, Feltmann K, Franck J, Schilström B, Carlsson A. The monoamine stabilizer (-)-OSU6162 attenuates voluntary ethanol intake and ethanol-induced dopamine output in nucleus accumbens. Biological Psychiatry. 72: 823-31. PMID 22817867 DOI: 10.1016/j.biopsych.2012.06.018  0.309
2011 Carlsson ML, Burstein ES, Kloberg A, Hansson S, Schedwin A, Nilsson M, Rung JP, Carlsson A. I. In vivo evidence for partial agonist effects of (-)-OSU6162 and (+)-OSU6162 on 5-HT2A serotonin receptors. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 1511-22. PMID 21874578 DOI: 10.1007/s00702-011-0704-8  0.402
2011 Burstein ES, Carlsson ML, Owens M, Ma JN, Schiffer HH, Carlsson A, Hacksell U. II. In vitro evidence that (-)-OSU6162 and (+)-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptors. Journal of Neural Transmission (Vienna, Austria : 1996). 118: 1523-33. PMID 21866391 DOI: 10.1007/s00702-011-0701-y  0.405
2011 Rung JP, Rung E, Johansson AM, Svensson K, Carlsson A, Carlsson ML. Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats. Naunyn-Schmiedeberg's Archives of Pharmacology. 384: 39-45. PMID 21533991 DOI: 10.1007/s00210-011-0641-y  0.469
2009 Carlsson A, Lindqvist M. Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse Brain Pharmacology & Toxicology. 20: 140-144. PMID 14060771 DOI: 10.1111/J.1600-0773.1963.Tb01730.X  0.313
2009 Nyberg P, Almay BGL, Carlsson A, Masters C, Winblad B. Brain monoamine abnormalities in the two types of Creutzfeldt-Jakob disease. Acta Neurologica Scandinavica. 66: 16-24. PMID 6180593 DOI: 10.1111/J.1600-0404.1982.Tb03125.X  0.316
2009 Carlsson A, Henning M, Lindberg P, Martinson P, Trolin G, Waldeck B, Wickberg B. On the Disulfiram-Like Effect of Coprine, the Pharmacologically Active Principle of Coprinus atramentarius Pharmacology & Toxicology. 42: 292-297. PMID 350009 DOI: 10.1111/J.1600-0773.1978.Tb02204.X  0.303
2009 Granérus A, Eriksson T, Magnusson T, Carlsson A. CORRELATION BETWEEN CONCENTRATION OF DOPA IN PLASMA AND THE “ON-OFF” PHENOMENON Acta Neurologica Scandinavica. 69: 47-48. DOI: 10.1111/J.1600-0404.1984.TB02383.X  0.492
2009 Carlsson A. The Search For New Monoaminergic Receptor Agonists Acta Neurologica Scandinavica. 65: 34-39. DOI: 10.1111/J.1600-0404.1982.Tb03375.X  0.324
2008 Carlsson A, Carlsson ML. Adaptive properties and heterogeneity of dopamine D(2) receptors - pharmacological implications. Brain Research Reviews. 58: 374-8. PMID 18511124 DOI: 10.1016/j.brainresrev.2007.09.007  0.403
2008 Rung JP, Rung E, Helgeson L, Johansson AM, Svensson K, Carlsson A, Carlsson ML. Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 899-908. PMID 18351286 DOI: 10.1007/s00702-008-0038-3  0.463
2007 Lahti RA, Tamminga CA, Carlsson A. Stimulating and inhibitory effects of the dopamine "stabilizer" (-)-OSU6162 on dopamine D2 receptor function in vitro. Journal of Neural Transmission (Vienna, Austria : 1996). 114: 1143-6. PMID 17612788 DOI: 10.1007/S00702-007-0784-7  0.435
2005 Rung JP, Carlsson A, Rydén Markinhuhta K, Carlsson ML. (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 29: 827-32. PMID 15916843 DOI: 10.1016/j.pnpbp.2005.03.004  0.325
2004 Nilsson M, Carlsson A, Markinhuhta KR, Sonesson C, Pettersson F, Gullme M, Carlsson ML. The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 28: 677-85. PMID 15276693 DOI: 10.1016/j.pnpbp.2004.05.004  0.307
2004 Carlsson ML, Carlsson A, Nilsson M. Schizophrenia: From dopamine to glutamate and back Current Medicinal Chemistry. 11: 267-277. PMID 14965231 DOI: 10.2174/0929867043456034  0.437
2003 Grunder G, Carlsson A, Wong DF. Mechanism of new antipsychotic medications: occupancy is not just antagonism. Archives of General Psychiatry. 60: 974-7. PMID 14557141 DOI: 10.1001/archpsyc.60.10.974  0.43
2003 Waters S, Kullingsjo J, Sonesson C, Carlsson A, Tedroff J, Waters N. Da stabilisers — fourth generation antipsychotic drugs Schizophrenia Research. 60: 119. DOI: 10.1016/S0920-9964(03)80879-4  0.31
2002 Tamminga CA, Carlsson A. Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis Curr Drug Target Cns Neurol Disord. 1: 141-147. PMID 12769623 DOI: 10.2174/1568007024606195  0.342
2001 Carlsson A. A half-century of neurotransmitter research: Impact on neurology and psychiatry Bioscience Reports. 21: 691-710. PMID 12166820 DOI: 10.1023/A:1015556204669  0.329
2001 Nilsson M, Waters S, Waters N, Carlsson A, Carlsson ML. A behavioural pattern analysis of hypoglutamatergic mice - Effects of four different antipsychotic agents Journal of Neural Transmission. 108: 1181-1196. PMID 11725821 DOI: 10.1007/s007020170008  0.342
2000 Kegeles LS, Abi-Dargham A, Zea-Ponce Y, Rodenhiser-Hill J, Mann JJ, Van Heertum RL, Cooper TB, Carlsson A, Laruelle M. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia Biological Psychiatry. 48: 627-640. PMID 11032974 DOI: 10.1016/S0006-3223(00)00976-8  0.424
2000 Carlsson A, Waters N, Waters S, Carlsson ML. Network interactions in schizophrenia - Therapeutic implications Brain Research Reviews. 31: 342-349. PMID 10719161 DOI: 10.1016/S0165-0173(99)00050-8  0.302
1999 Tedroff J, Ekesbo A, Sonesson C, Waters N, Carlsson A. Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease Neurology. 53: 1605-1606. PMID 10534281 DOI: 10.1212/Wnl.53.7.1605  0.313
1999 Carlsson ML, Martin P, Nilsson M, Sorensen SM, Carlsson A, Waters S, Waters N. The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice Journal of Neural Transmission. 106: 123-129. PMID 10226932 DOI: 10.1007/s007020050144  0.41
1999 Ekesbo A, Torstenson R, Hartvig P, Carlsson A, Sonesson C, Waters N, Tedroff J, Långström B. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains Neuropharmacology. 38: 331-338. PMID 10219971 DOI: 10.1016/S0028-3908(98)00200-7  0.426
1998 Lahti AC, Weiler M, Carlsson A, Tamminga CA. Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia. Journal of Neural Transmission (Vienna, Austria : 1996). 105: 719-34. PMID 9826114 DOI: 10.1007/S007020050091  0.426
1998 Martin P, Waters N, Schmidt CJ, Carlsson A, Carlsson ML. Rodent data and general hypothesis: Antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone Journal of Neural Transmission. 105: 365-396. PMID 9720968 DOI: 10.1007/s007020050064  0.453
1998 Tedroff J, Torstenson R, Hartvig P, Sonesson C, Waters N, Carlsson A, Neu H, Fasth KJ, Långström B. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: Evidence for tone-dependent normalization of striatal dopaminergic activity Synapse. 28: 280-287. PMID 9517836 DOI: 10.1002/(SICI)1098-2396(199804)28:4<280::AID-SYN3>3.0.CO;2-5  0.361
1998 Lahti AC, Weiler MA, Corey PK, Lahti RA, Carlsson A, Tamminga CA. Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia. Biological Psychiatry. 43: 2-11. PMID 9442338 DOI: 10.1016/S0006-3223(97)00030-9  0.379
1997 Nilsson M, Carlsson A, Carlsson ML. Glycine and D-serine decrease MK-801-induced hyperactivity in mice Journal of Neural Transmission. 104: 1195-1205. PMID 9503265 DOI: 10.1007/BF01294720  0.32
1997 Martin P, Waters NR, Waters SE, Carlsson A, Carlsson ML. MK-801-induced hyperlocomotion: Differential effects of m100907, SDZ PSD 958 and raclopride European Journal of Pharmacology. 335: 107-116. PMID 9369362 DOI: 10.1016/S0014-2999(97)01188-6  0.419
1997 Neu H, Hartvig P, Torstenson R, Fasth KJ, Sonesson C, Waters N, Carlsson A, Tedroff J, Långström B. Synthesis of [11 C-methyl]-(-)-OSU6162, its regional brain distribution and some pharmacological effects of (-)- OSU6162 on the dopaminergic system studied in the rhesus monkey by positron emission tomography Nuclear Medicine and Biology. 24: 507-511. PMID 9316077 DOI: 10.1016/S0969-8051(97)00023-1  0.385
1997 Martin P, Waters N, Carlsson A, Carlsson ML. The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin Journal of Neural Transmission. 104: 561-564. PMID 9295186 DOI: 10.1007/BF01277672  0.35
1997 Carlsson A, Hansson LO, Waters N, Carlsson ML. Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications Life Sciences. 61: 75-94. PMID 9217267 DOI: 10.1016/S0024-3205(97)00228-2  0.307
1997 Sonesson C, Wikström H, Smith MW, Svensson K, Carlsson A, Waters N. Regioselective synthesis of 3-aryl substituted pyrrolidines via palladium catalyzed arylation: Pharmacological evaluation for central dopaminergic and serotonergic activity Bioorganic and Medicinal Chemistry Letters. 7: 241-246. DOI: 10.1016/S0960-894X(96)00618-X  0.357
1997 Lahti AC, Lahti RA, Carlsson A, Tamminga CA. The treatment of schizophrenia with partial dopamine agonist: A promising strategy Schizophrenia Research. 24: 207. DOI: 10.1016/S0920-9964(97)82595-9  0.344
1996 Carlsson A. Stabilizing action of partial dopamine receptor agonists in psychosis European Neuropsychopharmacology. 6: 17. DOI: 10.1016/0924-977X(96)87377-9  0.312
1995 Svensson A, Carlsson ML, Carlsson A. Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice Journal of Neural Transmission. 101: 127-148. PMID 8695043 DOI: 10.1007/BF01271551  0.386
1995 Kujacic M, Hansson LO, Carlsson A. Acute dopaminergic influence on plasma adrenaline levels in the rat European Journal of Pharmacology. 273: 247-257. PMID 7737332 DOI: 10.1016/0014-2999(94)00699-8  0.463
1995 Sonesson C, Barf T, Nilsson J, Dijkstra D, Carlsson A, Svensson K, Smith MW, Martin IJ, Duncan JN, King LJ, Wikström H. Synthesis and evaluation of pharmacological and pharmacokinetic properties of monopropyl analogs of 5-, 7-, and 8-[[(trifluoromethyl)sulfonyl]oxy]-2-aminotetralins: Central dopamine and serotonin receptor activity Journal of Medicinal Chemistry. 38: 1319-1329. PMID 7731017 DOI: 10.1021/Jm00008A010  0.393
1995 Kujacic M, Carlsson A. In vivo activity of tyrosine hydroxylase in rat adrenal glands following administration of quinpirole and dopamine European Journal of Pharmacology. 278: 9-15. PMID 7664818 DOI: 10.1016/0014-2999(95)00092-Y  0.472
1995 Carlsson A. Towards a New Understanding of Dopamine Receptors Clinical Neuropharmacology. 18. DOI: 10.1097/00002826-199501001-00002  0.411
1995 Carlsson A, Piercey MF. Dopamine-Receptor Subtypes in Neurological and Psychiatric Disease: Introduction Clinical Neuropharmacology. 18. DOI: 10.1097/00002826-199501001-00001  0.397
1994 Waters N, Hansson L, Löfberg L, Carlsson A. Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo European Journal of Pharmacology. 251: 181-190. PMID 8149975 DOI: 10.1016/0014-2999(94)90399-9  0.454
1994 Sonesson C, Lin C, Hansson L, Waters N, Svensson K, Carlsson A, Smith MW, Wikström H. Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure-activity relationships. Journal of Medicinal Chemistry. 37: 2735-2753. PMID 8064801 DOI: 10.1021/Jm00043A013  0.43
1994 Stjernlöf P, Elebring T, Nilsson J, Andersson B, Lagerkvist S, Svensson K, Ekman A, Carlsson A, Wikström H. 6,7,8,9-Tetrahydro-N,N-di-n-propyl-3H-benzindol-8-amines. Derivatives as potent and orally active serotonin 5-HT1A receptor agonists Journal of Medicinal Chemistry. 37: 3263-3273. PMID 7932553 DOI: 10.1021/Jm00046A010  0.372
1994 Kujacic M, Carlsson A. I. c. v. dopamine fails to alter adrenomedullary function in rats Journal of Neural Transmission. 95: 235-240. PMID 7865178 DOI: 10.1007/BF01271569  0.44
1994 Carlsson ML, Engberg G, Carlsson A. Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice Journal of Neural Transmission. 95: 223-233. PMID 7865177 DOI: 10.1007/BF01271568  0.325
1994 Martin P, Svensson A, Carlsson A, Carlsson ML. On the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801 Journal of Neural Transmission. 95: 113-121. PMID 7865166 DOI: 10.1007/BF01276430  0.387
1994 Svensson K, Carlsson A, Waters N. Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release Journal of Neural Transmission. 95: 71-74. PMID 7857588 DOI: 10.1007/BF01283032  0.444
1994 Svensson A, Carlsson ML, Carlsson A. Glutamatergic neurons projecting to the nucleus accumbens can affect motor functions in opposite directions depending on the dopaminergic tone Progress in Neuropsychopharmacology and Biological Psychiatry. 18: 1203-1218. PMID 7846289 DOI: 10.1016/0278-5846(94)90121-X  0.365
1994 Kujacic M, Carlsson A. Influence of GBR 12909 and d-amphetamine on indices of catecholamine synthesis and release in rat adrenal glands Neuropharmacology. 33: 983-987. PMID 7845554 DOI: 10.1016/0028-3908(94)90156-2  0.425
1994 Svensson K, Carlsson A, Huff RM, Kling-Petersen T, Waters N. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors European Journal of Pharmacology. 263: 235-243. PMID 7843260 DOI: 10.1016/0014-2999(94)90718-8  0.467
1994 Kujacic M, Carlsson A. Effects of MPP+ on catecholamine levels in adrenal glands and heart of rats Naunyn-Schmiedeberg's Archives of Pharmacology. 350: 245-251. PMID 7824040 DOI: 10.1007/BF00175029  0.383
1994 Waters N, Löfberg L, Haadsma-Svensson S, Svensson K, Sonesson C, Carlsson A. Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour Journal of Neural Transmission. 98: 39-55. PMID 7710738 DOI: 10.1007/BF01277593  0.425
1994 Haadsma-Svensson SR, Smith MW, Lin CH, Neil Duncan J, Sonesson C, Wikström H, Waters N, Carlsson A, Svensson K. Synthesis and biological activity of C-5 modified derivatives of (+)-AJ76 and (+)-UH232: Increased dopamine D3 receptor preference and improved pharmacokinetic properties Bioorganic and Medicinal Chemistry Letters. 4: 689-694. DOI: 10.1016/S0960-894X(01)80181-5  0.365
1994 Lahti A, Lahti R, Carlsson A, Tamminga C. The efficacy of the partial dopamine agonist (-)-3PPP in schizophrenia Biological Psychiatry. 35: 746. DOI: 10.1016/0006-3223(94)91131-2  0.351
1993 Lin CH, Haadsma-Svensson SR, Phillips G, McCall RB, Piercey MF, Smith MW, Svensson K, Carlsson A, Chidester CG, Von Voigtlander PF. Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro-3-propyl-1H-benz[e]indole-9-carboxamide: A potent and selective 5-HT1A receptor agonist with good oral availability Journal of Medicinal Chemistry. 36: 2208-2218. PMID 8340922 DOI: 10.1021/Jm00067A018  0.311
1993 Waters N, Lagerkvist S, Löfberg L, Piercey M, Carlsson A. The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study. European Journal of Pharmacology. 242: 151-163. PMID 8253112 DOI: 10.1016/0014-2999(93)90075-S  0.461
1993 Sonesson C, Waters N, Svensson K, Carlsson A, Smith MW, Piercey MF, Meier E, Wikström H. Substituted 3-phenylpiperidines: New centrally acting dopamine autoreceptor antagonists Journal of Medicinal Chemistry. 36: 3188-3196. PMID 8230107 DOI: 10.1021/JM00073A021  0.364
1993 Waters N, Svensson K, Haadsma-Svensson SR, Smith MW, Carlsson A. The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. Journal of Neural Transmission. 94: 11-19. PMID 8129881 DOI: 10.1007/Bf01244979  0.449
1993 Kujacic M, Carlsson A. Evidence for an increased catecholamine synthesis in rat adrenal glands following stimulation of peripheral dopamine receptors Journal of Neural Transmission. 92: 73-79. PMID 8103662 DOI: 10.1007/Bf01244867  0.443
1993 Svensson K, Eriksson E, Carlsson A. Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: potential treatment of extrapyramidal side effects. Neuropharmacology. 32: 1037-1045. PMID 7905192 DOI: 10.1016/0028-3908(93)90069-F  0.452
1993 Carlsson ML, Svensson A, Carlsson A. Differential locomotor interactions between dopamine D1/D2 receptor agonists and NMDA antagonists Schizophrenia Research. 9: 234. DOI: 10.1016/0920-9964(93)90517-M  0.372
1993 Andersson B, Wikström H, Hjorth S, Svensson K, Carlsson A, Sundell S, Lundmark M, Largent B. Resolved 2-arylcyclohexylamines: Effects on reserpine akinesia and central nervous system monoamine synthesis European Journal of Medicinal Chemistry. 28: 63-69. DOI: 10.1016/0223-5234(93)90079-T  0.538
1992 Piercey MF, Lum JT, Hoffmann WE, Carlsson A, Ljung E, Svensson K. Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232. Brain Research. 588: 217-222. PMID 1393576 DOI: 10.1016/0006-8993(92)91578-3  0.32
1992 Svensson A, Carlsson A, Carlsson ML. Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice Journal of Neural Transmission. 90: 199-217. PMID 1363051 DOI: 10.1007/BF01250961  0.43
1992 Svensson A, Carlsson ML, Carlsson A. Interaction between glutamatergic and dopaminergic tone in the nucleus accumbens of mice: evidence for a dual glutamatergic function with respect to psychomotor control Journal of Neural Transmission. 88: 235-240. PMID 1358121 DOI: 10.1007/BF01244735  0.356
1991 Carlsson A, Fornstedt B. Catechol metabolites in the cerebrospinal fluid as possible markers in the early diagnosis of Parkinson's disease Neurology. 41: 50-51. PMID 2041593 DOI: 10.1212/Wnl.41.5_Suppl_2.50  0.305
1991 Fornstedt B, Carlsson A. Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum. Journal of Neurochemistry. 56: 407-414. PMID 1988547 DOI: 10.1111/J.1471-4159.1991.Tb08166.X  0.347
1991 Fornstedt B, Carlsson A. Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig. Neuropharmacology. 30: 463-8. PMID 1907723 DOI: 10.1016/0028-3908(91)90007-X  0.318
1991 Svensson A, Carlsson M, Carlsson A. Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 with regard to locomotor stimulation in monoamine-depleted mice Journal of Neural Transmission. 85: 69-77. PMID 1867840 DOI: 10.1007/BF01244659  0.402
1991 Kullingsjö H, Carlsson A, Svensson K. Effects of repeated administration of the preferential dopamine autoreceptor antagonist, (+)-AJ76, on locomotor activity and brain DA metabolism in the rat. European Journal of Pharmacology. 205: 241-246. PMID 1817961 DOI: 10.1016/0014-2999(91)90904-5  0.427
1991 Svensson K, Ekman A, Piercey MF, Hoffmann WE, Lum JT, Carlsson A. Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study. Naunyn-Schmiedebergs Archives of Pharmacology. 344: 263-274. PMID 1683686 DOI: 10.1007/Bf00182999  0.485
1991 Carlsson M, Svensson A, Carlsson A. Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice Naunyn-Schmiedeberg's Archives of Pharmacology. 343: 568-573. PMID 1682816 DOI: 10.1007/BF00184286  0.37
1991 Kujacic M, Svensson K, Löfberg L, Carlsson A. Dopamine receptors, controlling dopamine levels in rat adrenal glands — comparison with central dopaminergic autoreceptors Journal of Neural Transmission. 84: 195-209. PMID 1679336 DOI: 10.1007/Bf01244970  0.482
1990 Fornstedt B, Pileblad E, Carlsson A. In Vivo Autoxidation of Dopamine in Guinea Pig Striatum Increases with Age Journal of Neurochemistry. 55: 655-659. PMID 2370552 DOI: 10.1111/J.1471-4159.1990.Tb04183.X  0.347
1990 Allard P, Alafuzoff I, Carlsson A, Eriksson K, Ericson E, Gottfries CG, Marcusson JO. Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's disease. European Neurology. 30: 181-5. PMID 2209670 DOI: 10.1159/000117341  0.302
1990 Johansson AM, Fredriksson K, Hacksell U, Grol CJ, Svensson K, Carlsson A, Sundell S. Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralin. Journal of Medicinal Chemistry. 33: 2925-2929. PMID 2120444 DOI: 10.1021/Jm00172A038  0.414
1990 Fornstedt B, Bergh I, Rosengren E, Carlsson A. An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid. Journal of Neurochemistry. 54: 578-86. PMID 2105377 DOI: 10.1111/j.1471-4159.1990.tb01910.x  0.567
1990 Waters N, Löfberg L, Svensson K, Carlsson A. Increased dopamine release by the autoreceptor antagonist (+)-AJ 76 is Ca2(+)-dependent. European Journal of Pharmacology. 187: 425-434. PMID 2073922 DOI: 10.1016/0014-2999(90)90369-H  0.389
1990 Carlsson M, Carlsson A. Schizophrenia: A Subcortical Neurotransmitter Imbalance Syndrome? Schizophrenia Bulletin. 16: 425-432. PMID 1981107 DOI: 10.1093/Schbul/16.3.425  0.329
1990 Kujacic M, Svensson K, Löfberg L, Carlsson A. Acute changes in dopamine levels in rat adrenal glands after administration of dopamine receptor agonists and antagonists European Journal of Pharmacology. 177: 163-170. PMID 1968848 DOI: 10.1016/0014-2999(90)90266-9  0.47
1990 Carlsson M, Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease Trends in Neurosciences. 13: 272-276. PMID 1695402 DOI: 10.1016/0166-2236(90)90108-M  0.373
1989 Fornstedt B, Brun A, Rosengren E, Carlsson A. The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. Journal of Neural Transmission. Parkinson's Disease and Dementia Section. 1: 279-95. PMID 2597314 DOI: 10.1007/BF02263482  0.533
1989 Waters N, Pettersson G, Carlsson A, Svensson K. The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization. Naunyn-Schmiedebergs Archives of Pharmacology. 340: 161-169. PMID 2572972 DOI: 10.1007/Bf00168964  0.387
1989 Wikström H, Andersson B, Svensson A, Humber LG, Asselin AA, Svensson K, Ekman A, Carlsson A, Nilsson I, Chidester C. Resolved 6,7,8,9-tetrahydro-N,N-dimethyl-3H-benz[e]indol-8-amine: central dopamine and serotonin receptor stimulating properties Journal of Medicinal Chemistry. 32: 2273-2276. PMID 2571729 DOI: 10.1021/Jm00130A008  0.401
1989 Nissbrandt H, Sundström E, Jonsson G, Hjorth S, Carlsson A. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum. Journal of Neurochemistry. 52: 1170-82. PMID 2564423 DOI: 10.1111/J.1471-4159.1989.Tb01863.X  0.631
1989 Carlsson M, Carlsson A. Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice Journal of Neural Transmission. 77: 65-71. PMID 2545813 DOI: 10.1007/Bf01255820  0.341
1989 Carlsson M, Carlsson A. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice Journal of Neural Transmission. 75: 221-226. PMID 2538557 DOI: 10.1007/Bf01258633  0.323
1989 Fornstedt B, Carlsson A. A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment. Journal of Neural Transmission. 76: 155-61. PMID 2496196 DOI: 10.1007/BF01578755  0.304
1988 Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Lindberg P, Andersson B. N,N-Dialkylated monophenolic trans-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonists. Journal of Medicinal Chemistry. 31: 92-9. PMID 3336037  0.668
1988 Pileblad E, Carlsson A. Studies on the Acute and Long-Term Changes in Dopamine and Noradrenaline Metabolism in Mouse Brain Following Administration of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Pharmacology & Toxicology. 62: 213-222. PMID 3260379 DOI: 10.1111/J.1600-0773.1988.Tb01875.X  0.444
1988 Hajós M, Engberg G, Nissbrandt H, Magnusson T, Carlsson A. Capsaicin-sensitive vasodilatatory mechanisms in the rat substantia nigra and striatum. Journal of Neural Transmission. 74: 129-39. PMID 3210010 DOI: 10.1007/BF01244779  0.593
1988 Hjorth S, Clark D, Carlsson A. Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation. European Journal of Pharmacology. 152: 207-15. PMID 3146512 DOI: 10.1016/0014-2999(88)90715-7  0.679
1988 Nissbrandt H, Engberg G, Wikström H, Magnusson T, Carlsson A. NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 338: 148-61. PMID 3141816 DOI: 10.1007/BF00174863  0.646
1988 Hajos M, Hjorth S, Svensson K, Carlsson A. In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion. Experimental Brain Research. 70: 577-84. PMID 3133239 DOI: 10.1007/BF00247605  0.592
1988 Hjorth S, Carlsson A. In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390. Journal of Neural Transmission. 72: 83-97. PMID 2968439 DOI: 10.1007/BF01250232  0.6
1988 Wikstrom H, Elebring T, Hallnemo G, Andersson B, Svensson K, Carlsson A, Rollema H. Occurrence and pharmacological significance of metabolic ortho-hydroxylation of 5- and 8-hydroxy-2-(di-n-propylamino)tetralin Journal of Medicinal Chemistry. 31: 1080-1084. PMID 2967374 DOI: 10.1021/Jm00401A005  0.302
1988 Snape BM, Pileblad E, Ekman A, Magnusson T, Carlsson A, Engel J. The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices. The Journal of Pharmacy and Pharmacology. 40: 620-6. PMID 2907028 DOI: 10.1111/j.2042-7158.1988.tb05321.x  0.715
1988 Eriksson T, Carlsson A. β-adrenergic control of brain uptake of large neutral amino acids Life Sciences. 42: 1583-1589. PMID 2835561 DOI: 10.1016/0024-3205(88)90436-5  0.303
1988 Carlsson M, Carlsson A. In vivo evidence for a greater brain tryptophan hydroxylase capacity in female than in male rats. Naunyn-Schmiedebergs Archives of Pharmacology. 338: 345-349. PMID 2469019 DOI: 10.1007/Bf00172108  0.318
1988 Carlsson M, Carlsson A. A regional study of sex differences in rat brain serotonin Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: 53-61. PMID 2452455 DOI: 10.1016/0278-5846(88)90061-9  0.347
1987 Carlsson M, Carlsson A, Eriksson E. The intrinsic activities of the partial dopamine receptor agonists (-)-3-PPP and TDHL on pituitary dopamine receptors are lower in female than in male rats. European Journal of Pharmacology. 142: 39-43. PMID 3691635 DOI: 10.1016/0014-2999(87)90651-0  0.404
1987 Johansson AM, Nilsson JL, Karlén A, Hacksell U, Sanchez D, Svensson K, Hjorth S, Carlsson A, Sundell S, Kenne L. C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors. Journal of Medicinal Chemistry. 30: 1827-37. PMID 3656358 DOI: 10.1021/JM00393A025  0.568
1987 Johansson AM, Nilsson JLG, Karlen A, Hacksell U, Svensson K, Carlsson A, Kenne L, Sundell S. C3-methylated 5-hydroxy-2-(dipropylamino)tetralins: conformational and steric parameters of importance for central dopamine receptor activation. Journal of Medicinal Chemistry. 30: 1135-1144. PMID 3599021 DOI: 10.1021/Jm00390A004  0.425
1987 Svensson K, Alföldi P, Hajós M, Rubicsek G, Johansson AM, Carlsson A, Obál F. Dopamine autoreceptor antagonists: effects on sleep-wake activity in the rat. Pharmacology, Biochemistry and Behavior. 26: 123-129. PMID 3562484 DOI: 10.1016/0091-3057(87)90544-2  0.304
1987 Johansson AM, Arvidsson L-, Hacksell U, Nilsson JLG, Svensson K, Carlsson A. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists. Journal of Medicinal Chemistry. 30: 602-611. PMID 3560156 DOI: 10.1021/Jm00387A004  0.439
1987 Ahlenius S, Carlsson A, Hillegaart V, Hjorth S, Larsson K. Region-selective activation of brain monoamine synthesis by sexual activity in the male rat. European Journal of Pharmacology. 144: 77-82. PMID 3436362 DOI: 10.1016/0014-2999(87)90011-2  0.575
1987 Hjorth S, Carlsson A, Engel JA. Anxiolytic-like action of the 3-PPP enantiomers in the Vogel conflict paradigm. Psychopharmacology. 92: 371-5. PMID 3114790 DOI: 10.1007/BF00210846  0.686
1987 Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Andersson B, Wikström H. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist. Journal of Medicinal Chemistry. 30: 2105-9. PMID 2959776 DOI: 10.1021/Jm00394A029  0.698
1987 Hjorth S, Carlsson A. Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393. Psychopharmacology. 93: 534-7. PMID 2893419 DOI: 10.1007/BF00207249  0.555
1987 Wikström H, Andersson B, Elebring T, Svensson K, Carlsson A, Largent B. N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors. Journal of Medicinal Chemistry. 30: 2169-74. PMID 2824773 DOI: 10.1021/Jm00395A002  0.375
1987 Hajós M, Hjorth S, Carlsson A. Injection of capsaicin into the nucleus raphe dorsalis elicits heat loss in the rat. Neuroscience Letters. 75: 199-204. PMID 2437500 DOI: 10.1016/0304-3940(87)90297-7  0.544
1987 Pileblad E, Carlsson A. In vivo effects of the Ca2+-antagonist nimodipine on dopamine metabolism in mouse brain. Journal of Neural Transmission. 66: 171-87. PMID 2431107 DOI: 10.1007/BF01260912  0.323
1986 Svensson K, Carlsson A, Johansson AM, Arvidsson LE, Nilsson JLG. A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptors. Journal of Neural Transmission. 65: 29-38. PMID 3958706 DOI: 10.1007/Bf01249609  0.46
1986 Gottfries C, Bartfai T, Carlsson A, Eckerkäs S, Svennerholm L. Multiple biochemical deficits in both gray and white matter of Alzheimer brains Progress in Neuro-Psychopharmacology & Biological Psychiatry. 10: 405-413. PMID 3797685 DOI: 10.1016/0278-5846(86)90014-X  0.319
1986 Svensson K, Carlsson M, Carlsson A, Hjorth S, Johansson AM, Eriksson E. The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats. European Journal of Pharmacology. 130: 237-42. PMID 3792447 DOI: 10.1016/0014-2999(86)90273-6  0.659
1986 Carlsson W, Eriksson E, Nilsson C, Carlsson A. Sexually differentiated actions of 3-PPP enantiomers on prolactin secretion Neuropharmacology. 25: 951-954. PMID 3774120 DOI: 10.1016/0028-3908(86)90028-6  0.355
1986 Hjorth S, Svensson K, Carlsson A, Wikström H, Andersson B. Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP. Naunyn-Schmiedeberg's Archives of Pharmacology. 333: 205-18. PMID 3762735 DOI: 10.1007/Bf00512931  0.658
1986 Rollema H, Mastebroek D, Wikstrom H, Svensson K, Carlsson A, Sundell S. Enantiomers of 3-(3,4-dihydroxyphenyl)- and 3-(3-hydroxyphenyl)-N-n-propylpiperidine: central pre- and postsynaptic dopaminergic effects and pharmacokinetics. Journal of Medicinal Chemistry. 29: 1889-1895. PMID 3761308 DOI: 10.1021/Jm00160A016  0.342
1986 Fornstedt B, Rosengren E, Carlsson A. Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species. Neuropharmacology. 25: 451-4. PMID 3086766 DOI: 10.1016/0028-3908(86)90242-X  0.576
1986 Svensson K, Hjorth S, Clark D, Carlsson A, Wikström H, Andersson B, Sanchez D, Johansson AM, Arvidsson LE, Hacksell U. (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors. Journal of Neural Transmission. 65: 1-27. PMID 3083041 DOI: 10.1007/BF01249608  0.62
1986 Hjorth S, Engel JA, Carlsson A. Anticonflict effects of low doses of the dopamine agonist apomorphine in the rat. Pharmacology, Biochemistry, and Behavior. 24: 237-40. PMID 3006085 DOI: 10.1016/0091-3057(86)90344-8  0.7
1986 Svensson K, Johansson AM, Magnusson T, Carlsson A. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists. Naunyn-Schmiedeberg's Archives of Pharmacology. 334: 234-45. PMID 2880302 DOI: 10.1007/BF00508777  0.658
1986 Hjorth S, Carlsson A. Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? European Journal of Pharmacology. 129: 131-8. PMID 2429847 DOI: 10.1016/0014-2999(86)90344-4  0.589
1986 Eriksson T, Wiesel K, Carlsson A. Rat brain concentration of administered amino acids: dependence on time of day for administration. Journal of Neural Transmission. 65: 83-91. PMID 2420927 DOI: 10.1007/Bf01249614  0.31
1985 Carlsson A, Löfberg L. In vivo displacement by 3-PPP enantiomers of N,N-dipropyl-5,6-ADTN from dopamine receptor-binding sites in rat striatum. Journal of Neural Transmission. 64: 173-185. PMID 4086990 DOI: 10.1007/Bf01256465  0.346
1985 Clark D, Engberg G, Pileblad E, Svensson TH, Carlsson A, Freeman AS, Bunney BS. An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system. Naunyn-Schmiedeberg's Archives of Pharmacology. 329: 344-54. PMID 4033804 DOI: 10.1007/BF00496366  0.555
1985 Hjorth S, Carlsson A, Clark D, Svensson K, Sanchez D. Dopamine receptor-mediated hypothermia induced in rats by (+)-, but not by (-)-3-PPP. European Journal of Pharmacology. 107: 299-304. PMID 3979430 DOI: 10.1016/0014-2999(85)90254-7  0.695
1985 Wikström H, Andersson B, Sanchez D, Lindberg P, Arvidsson LE, Johansson AM, Nilsson JL, Svensson K, Hjorth S, Carlsson A. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists. Journal of Medicinal Chemistry. 28: 215-25. PMID 3968686 DOI: 10.1021/Jm00380A012  0.626
1985 Hjorth S, Clark D, Svensson K, Carlsson A, Thorberg O. Sub-chronic administration of (-)-3-PPP and central dopamine receptor sensitivity changes. Journal of Neural Transmission. 64: 187-98. PMID 3936899 DOI: 10.1007/Bf01256466  0.639
1985 Clark D, Hjorth S, Carlsson A. Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence. Journal of Neural Transmission. 62: 1-52. PMID 3894582 DOI: 10.1007/Bf01260414  0.647
1985 Carlsson A. Pharmacological properties of presynaptic dopamine receptor agonists Psychopharmacology. Supplementum. 2: 31-38. PMID 3858802 DOI: 10.1007/978-3-642-70140-5_4  0.338
1985 Rosengren E, Linder-Eliasson E, Carlsson A. Detection of 5-S-cysteinyldopamine in human brain. Journal of Neural Transmission. 63: 247-53. PMID 3840838 DOI: 10.1007/BF01252029  0.56
1985 Nissbrandt H, Pileblad E, Carlsson A. Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra. Journal of Pharmacy and Pharmacology. 37: 884-889. PMID 2868096 DOI: 10.1111/J.2042-7158.1985.Tb04994.X  0.43
1985 Hjorth S, Carlsson A. (-)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis. Neuropharmacology. 24: 1143-6. PMID 2867485 DOI: 10.1016/0028-3908(85)90207-2  0.542
1985 Clark D, Hjorth S, Carlsson A. Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. Journal of Neural Transmission. 62: 171-207. PMID 2863323 DOI: 10.1007/Bf01252236  0.627
1985 Pileblad E, Fornstedt B, Clark D, Carlsson A. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum. The Journal of Pharmacy and Pharmacology. 37: 707-11. PMID 2416901 DOI: 10.1111/J.2042-7158.1985.Tb04947.X  0.44
1985 Carlsson M, Svensson K, Eriksson E, Carlsson A. Rat brain serotonin: Biochemical and functional evidence for a sex difference Journal of Neural Transmission. 63: 297-313. PMID 2415675 DOI: 10.1007/Bf01252033  0.316
1985 Hjorth S, Clark D, Carlsson A. Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: discrepancies between in vitro and in vivo observations. Life Sciences. 37: 673-84. PMID 2410756 DOI: 10.1016/0024-3205(85)90435-7  0.686
1985 Johansson AM, Arvidsson L-, Hacksell U, Nilsson JLG, Svensson K, Hjorth S, Clark D, Carlsson A, Sanchez D, Andersson B, Wikstroem H. Novel Dopamine Receptor Agonists And Antagonists With Preferential Action On Autoreceptors Cheminform. 16. DOI: 10.1002/Chin.198548162  0.636
1985 Wikstroem H, Andersson B, Sanchez D, Lindberg P, Arvidsson L-, Johansson AM, Nilsson JLG, Svensson K, Hjorth S, Carlsson A. Resolved Monophenolic 2-Aminotetralins And 1,2,3,4,4A,5,6,10B-Octahydrobenzo(F)Quinolines: Structural And Stereochemical Considerations For Centrally Acting Pre- And Postsynaptic Dopamine-Receptor Agonists Cheminform. 16. DOI: 10.1002/Chin.198524182  0.582
1985 Wikstroem H, Sanchez D, Lindberg P, Hacksell U, Arvidsson L-, Johansson AM, Thorberg S-, Nilsson JLG, Svensson K, Hjorth S, Clark D, Carlsson A. Resolved 3-(3-Hydroxyphenyl)-N-N-Propylpiperidine And Its Analogs: Central Dopamine Receptor Activity Cheminform. 16. DOI: 10.1002/Chin.198503222  0.597
1985 Hacksell U, Johansson AM, Arvidsson L-, Nilsson JLG, Hjorth S, Carlsson A, Wikstroem H, Sanchez D, Lindberg P. C1-Methylated 5-Hydroxy-2-(Dipropylamino)Tetralins: Central Dopamine-Receptor Stimulating Activity Cheminform. 16. DOI: 10.1002/Chin.198503183  0.611
1984 Hacksell U, Johansson AM, Arvidsson L, Nilsson JL, Hjorth S, Carlsson A, Wikström H, Sanchez D, Lindberg P. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity. Journal of Medicinal Chemistry. 27: 1003-7. PMID 6431102 DOI: 10.1021/Jm00374A012  0.648
1984 Eriksson T, Magnusson T, Carlsson A, Linde A, Granérus AK. "On-off" phenomenon in Parkinson's disease: correlation to the concentration of dopa in plasma. Journal of Neural Transmission. 59: 229-40. PMID 6429277 DOI: 10.1007/BF01250010  0.517
1984 Arvidsson LE, Hacksell U, Johansson AM, Nilsson JL, Lindberg P, Sanchez D, Wikström H, Svensson K, Hjorth S, Carlsson A. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists. Journal of Medicinal Chemistry. 27: 45-51. PMID 6418888 DOI: 10.1021/Jm00367A009  0.594
1984 Engel JA, Hjorth S, Svensson K, Carlsson A, Liljequist S. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). European Journal of Pharmacology. 105: 365-8. PMID 6239785 DOI: 10.1016/0014-2999(84)90634-4  0.678
1984 Clark D, Hjorth S, Carlsson A. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis. European Journal of Pharmacology. 106: 185-9. PMID 6099268 DOI: 10.1016/0014-2999(84)90694-0  0.682
1984 Pileblad E, Nissbrandt H, Carlsson A. Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (NMPTP) in mouse brain Journal of Neural Transmission. 60: 199-203. DOI: 10.1007/978-1-349-07431-0_54  0.35
1984 Arvidsson L-, Hacksell U, Johansson AM, Nilsson JLG, Lindberg P, Sanchez D, Wikstroem H, Svensson K, Hjorth S, Carlsson A. 8-Hydroxy-2-(Alkylamino)Tetralins And Related Compounds As Central 5-Hydroxytryptamine Receptor Agonists Cheminform. 15. DOI: 10.1002/Chin.198424168  0.562
1983 Häggström JE, Gunne LM, Carlsson A, Wikström H. Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias Journal of Neural Transmission. 58: 135-142. PMID 6663299 DOI: 10.1007/Bf01252800  0.363
1983 Eriksson E, Modigh K, Carlsson A, Wikström H. Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers. European Journal of Pharmacology. 96: 29-36. PMID 6662196 DOI: 10.1016/0014-2999(83)90525-3  0.476
1983 Eriksson T, Magnusson T, Carlsson A, Hagman M, Jagenburg R. Decrease in plasma amino acids in man after an acute dose of ethanol. Journal of Studies On Alcohol. 44: 215-21. PMID 6645507 DOI: 10.15288/Jsa.1983.44.215  0.455
1983 Carlsson A. Dopamine receptor agonists: Intrinsic activity vs. state of receptor Journal of Neural Transmission. 57: 309-315. PMID 6418858 DOI: 10.1007/BF01249001  0.415
1983 Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson LE, Johansson A. Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Psychopharmacology. 81: 89-99. PMID 6415751 DOI: 10.1007/BF00428999  0.605
1983 Clark D, Carlsson A, Hjorth S, Engel J, Lindberg P. The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat. Psychopharmacology. 81: 14-7. PMID 6138790 DOI: 10.1007/BF00439266  0.736
1983 Hjorth S, Carlsson A, Clark D, Svensson K, Wikström H, Sanchez D, Lindberg P, Hacksell U, Arvidsson L-, Johansson A, Nilsson JLG. The search for selective dopaminergic autoreceptor agonists. Journal of Neural Transmission-Supplement. 18: 131-137. DOI: 10.1007/978-3-7091-4408-4_12  0.636
1983 Wikstroem H, Sanchez D, Lindberg P, Arvidsson L-, Hacksell U, Johansson A, Nilsson JLG, Hjorth S, Carlsson A. Monophenolic Octahydrobenzo(F)Quinolines: Central Dopamine- And Serotonin-Receptor Stimulating Activity Cheminform. 14. DOI: 10.1002/Chin.198303246  0.613
1982 Eriksson T, Carlsson A. Adrenergic influence on rat plasma concentrations of tyrosine and tryptophan. Life Sciences. 30: 1465-1472. PMID 7087675 DOI: 10.1016/0024-3205(82)90560-4  0.317
1982 Sakabe T, Dahlgren N, Carlsson A, Siesjö BK. Effect of diazepam on cerebral monoamine synthesis during hypoxia and hypercapnia in the rat Acta Physiologica Scandinavica. 115: 57-65. PMID 6814196 DOI: 10.1111/J.1748-1716.1982.Tb07045.X  0.36
1982 Eriksson T, Carlsson A. Isoprenaline increases brain concentrations of administered L-dopa and L-tryptophan in the rat. Psychopharmacology. 77: 98-100. PMID 6812125 DOI: 10.1007/Bf00436106  0.325
1982 Jackson D, Carlsson A, Hjorth S, Lindberg P. A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine). Journal of Neural Transmission. 53: 233-45. PMID 6286867 DOI: 10.1007/Bf01252035  0.619
1982 Hjorth S, Carlsson A. Buspirone: effects on central monoaminergic transmission--possible relevance to animal experimental and clinical findings. European Journal of Pharmacology. 83: 299-303. PMID 6129148 DOI: 10.1016/0014-2999(82)90265-5  0.627
1982 Clark D, Carlsson A, Hjorth S, Svensson K, Engel J, Sanchez D. Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioral studies. European Journal of Pharmacology. 83: 131-4. PMID 6127226 DOI: 10.1016/0014-2999(82)90297-7  0.703
1982 Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikström H, Arvidsson LE, Hacksell U, Nilsson JLG. 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity Journal of Neural Transmission. 55: 169-188. DOI: 10.1007/Bf01276574  0.583
1982 Nyberg P, Carlsson A, Winblad B. Brain monoamines in cases with Down's syndrome with and without dementia Journal of Neural Transmission. 55: 289-299. DOI: 10.1007/Bf01243450  0.362
1982 Hacksell U, Arvidsson L-, Svensson U, Nilsson JLG, Sanchez D, Wikstroem H, Lindberg P, Hjorth S, Carlsson A. 3-Phenylpiperidines. Central Dopamine-Autoreceptor Stimulating Activity Cheminform. 13. DOI: 10.1002/Chin.198222234  0.606
1982 Arvidsson L-, Hacksell U, Nilsson JLG, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstroem H. 8-Hydroxy-2-(Dipropylamino)Tetralin, A New Centrally Acting 5-Hydroxytryptamine Receptor Agonist Cheminform. 13. DOI: 10.1002/Chin.198203137  0.572
1981 Eriksson T, Magnusson T, Carlsson A, Hagman M, Jagenburg R, Edén S. Effects of hypophysectomy, adrenalectomy and (-)-propranolol on ethanol-induced decrease in plasma amino acids. Naunyn-Schmiedeberg's Archives of Pharmacology. 317: 214-8. PMID 7322213 DOI: 10.1007/BF00503819  0.48
1981 Carlsson A, Fowler CJ, Magnusson T, Oreland L, Wiberg A. The activities of monoamine oxidase-A and -B, succinate dehydrogenase and acid phosphatase in the rat brain after hemitransection. Naunyn-Schmiedeberg's Archives of Pharmacology. 316: 51-5. PMID 7279004 DOI: 10.1007/BF00507227  0.545
1981 Hacksell U, Arvidsson LE, Svensson U, Nilsson JL, Wikström H, Lindberg P, Sanchez D, Hjorth S, Carlsson A, Paalzow L. Monophenolic 2-(dipropylamino)indans and related compounds: central dopamine-receptor stimulating activity. Journal of Medicinal Chemistry. 24: 429-34. PMID 7265130 DOI: 10.1021/Jm00136A012  0.626
1981 Carlsson A. Some current problems related to the mode of action of antidepressant drugs Acta Psychiatrica Scandinavica. 63: 63-66. PMID 6939325 DOI: 10.1111/J.1600-0447.1981.Tb00709.X  0.354
1981 Arvidsson LE, Hacksell U, Nilsson JL, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstrom H. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. Journal of Medicinal Chemistry. 24: 921-3. PMID 6460101 DOI: 10.1021/Jm00140A002  0.572
1981 Ahlenius S, Larsson K, Svensson L, Hjorth S, Carlsson A, Lindberg P, Wikström H, Sanchez D, Arvidsson LE, Hacksell U, Nilsson JL. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacology, Biochemistry, and Behavior. 15: 785-92. PMID 6458826 DOI: 10.1016/0091-3057(81)90023-X  0.566
1981 Hjorth S, Carlsson A, Wikström H, Lindberg P, Sanchez D, Hacksell U, Arvidsson LE, Svensson U, Nilsson JL. 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors. Life Sciences. 28: 1225-38. PMID 6112651 DOI: 10.1016/0024-3205(81)90448-3  0.671
1981 Hacksell U, Arvidsson L-, Svensson U, Nilsson JLG, Wikstroem H, Lindberg P, Sanchez D, Hjorth S, Carlsson A, Paalzow L. Monophenolic 2-(Dipropylamino)Indans And Related Compounds: Central Dopamine-Receptor Stimulating Activity Cheminform. 12. DOI: 10.1002/Chin.198134192  0.615
1980 Oreland L, Fowler CJ, Carlsson A, Magnusson T. Monoamine oxidase -A and -B activity in the rat brain after hemitransection. Life Sciences. 26: 139-46. PMID 7366322 DOI: 10.1016/0024-3205(80)90058-2  0.541
1980 García-Sevilla JA, Magnusson T, Carlsson A. Effects of enkephalins and two enzyme resistant analogues on monoamine synthesis and metabolism in rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology. 310: 211-8. PMID 6103517 DOI: 10.1007/Bf00499912  0.602
1980 Hacksell U, Svensson U, Nilsson JLG, Hjorth S, Carlsson A, Wikstroem H, Lindberg P, Sanchez D. N-Alkylated 2-Aminotetralins: Central Dopamine-Receptor Stimulating Activity Cheminform. 11. DOI: 10.1002/Chin.198015191  0.623
1979 Garcia-Sevilla JA, Magnusson T, Carlsson A. Opposite effects of naloxone on substance P-induced changes in brain DOPA synthesis and in locomotor activity in rats. Journal of Neural Transmission. 45: 185-93. PMID 479872 DOI: 10.1007/Bf01244407  0.609
1979 Agardh C, Carlsson A, Linqvist M, Siesjö B. The effect of pronounced hypoglycemia on monoamine metabolism in rat brain Diabetes. 28: 804-809. PMID 467805 DOI: 10.2337/Diab.28.9.804  0.386
1979 Ahtee L, Carlsson A. Dual action of methadone on 5-HT synthesis and metabolism. Naunyn-Schmiedebergs Archives of Pharmacology. 307: 51-56. PMID 314596 DOI: 10.1007/Bf00506551  0.332
1979 Carlsson A, Lindqvist M. Effects of antidepressant agents on the synthesis of brain monoamines. Journal of Neural Transmission. 43: 73-91. PMID 215722 DOI: 10.1007/BF01579067  0.326
1979 Engel J, Ahlenius S, Almgren O, Carlsson A, Larsson K, Södersten P. Effects of gonadectomy and hormone replacement on brain monoamine synthesis in male rats. Pharmacology, Biochemistry and Behavior. 10: 149-154. PMID 35791 DOI: 10.1016/0091-3057(79)90181-3  0.551
1979 Wikstroem H, Lindberg P, Martinson P, Hjorth S, Carlsson A, Hacksell U, Svensson U, Nilsson JLG. Pivaloyl Esters Of N,N‐Dialkylated Dopamine Congeners. Central Dopamine‐Receptor Stimulating Activity Cheminform. 10. DOI: 10.1002/Chin.197908144  0.602
1978 García-Sevilla JA, Magnusson T, Carlsson A, Leban J, Folkers K. Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnover. Naunyn-Schmiedeberg's Archives of Pharmacology. 305: 213-8. PMID 740049 DOI: 10.1007/Bf00498813  0.596
1978 Calderini G, Carlsson A, Nordstro¨m C. Influence of transient ischemia on monoamine metabolism in the rat brain during nitrous oxide and phenobarbitone anaesthesia. Brain Research. 157: 303-310. PMID 309781 DOI: 10.1016/0006-8993(78)90032-X  0.385
1978 Calderini G, Carlsson A, Nordstro¨m C. Monoamine metabolism during bicuculline-induced epileptic seizures in the rat Brain Research. 157: 295-302. PMID 309780 DOI: 10.1016/0006-8993(78)90031-8  0.383
1978 Garcia-Sevilla JA, Magnusson T, Carlsson A. Effect of intracerebroventricularly administered somatostatin on brain monoamine turnover. Brain Research. 155: 159-64. PMID 308386 DOI: 10.1016/0006-8993(78)90318-9  0.552
1978 Biswas B, Carlsson A. On the mode of action of diazepam on brain catecholamine metabolism Naunyn-Schmiedeberg's Archives of Pharmacology. 303: 73-78. PMID 307697 DOI: 10.1007/BF00496187  0.393
1978 Biswas B, Carlsson A. Effect of intraperitoneally administered GABA on the locomotor activity of mice Psychopharmacology. 59: 91-94. PMID 100821 DOI: 10.1007/BF00428037  0.303
1978 Garcia-Sevilla JA, Ahtee L, Magnusson T, Carlsson A. Opiate-receptor mediated changes in monoamine synthesis in rat brain. The Journal of Pharmacy and Pharmacology. 30: 613-21. PMID 30814 DOI: 10.1111/J.2042-7158.1978.Tb13342.X  0.613
1978 Biswas B, Carlsson A. Potentiation by neuroleptic agents of the inhibitory action of intraperitoneally administered GABA on the locomotor activity of mice Pharmacology, Biochemistry and Behavior. 8: 651-654. PMID 29313 DOI: 10.1016/0091-3057(78)90261-7  0.364
1977 Ohman R, Larsson M, Nilsson IM, Engel J, Carlsson A. Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain. Naunyn-Schmiedeberg's Archives of Pharmacology. 299: 105-14. PMID 909609 DOI: 10.1007/BF00498552  0.508
1977 Biswas B, Carlsson A. The effect of intraperitoneally administered GABA on brain monoamine metabolism Naunyn-Schmiedeberg's Archives of Pharmacology. 299: 47-51. PMID 904694 DOI: 10.1007/BF00508636  0.383
1977 Biswas B, Carlsson A. The effect of intracerebroventricularly administered GABA on brain monoamine metabolism Naunyn-Schmiedeberg's Archives of Pharmacology. 299: 41-46. PMID 904693 DOI: 10.1007/BF00508635  0.372
1977 Strömbom U, Svensson TH, Carlsson A. Antagonism of Ethanol's Central Stimulation in Mice by Small Doses of Catecholamine-Receptor Agonists Psychopharmacology. 51: 293-299. PMID 403547 DOI: 10.1007/Bf00431639  0.355
1977 Carlsson A, Kehr W, Lindqvist M. Agonist--antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation. Journal of Neural Transmission. 40: 99-113. PMID 323424 DOI: 10.1007/Bf01250562  0.439
1977 Kehr W, Carlsson A, Lindqvist M. Catecholamine synthesis in rat brain after axotomy: interaction between apomorphine and haloperidol. Naunyn-Schmiedebergs Archives of Pharmacology. 297: 111-117. PMID 193050 DOI: 10.1007/Bf00499920  0.398
1977 Carlsson A, Holmin T, Lindqvist M, Siesjo BK. Effect of hypercapnia and hypocapnia on tryptophan and tyrosine hydroxylation in rat brain. Acta Physiologica Scandinavica. 99: 503-509. PMID 16438 DOI: 10.1111/J.1748-1716.1977.Tb10404.X  0.345
1976 Carlsson A, Kehr W, Lindqvist M. The role of intraneuronal amine levels in the feedback control of dopamine, noradrenaline and 5-hydroxytryptamine synthesis in rat brain. Journal of Neural Transmission. 39: 1-19. PMID 1086343 DOI: 10.1007/Bf01248762  0.434
1976 Cott J, Carlsson A, Engel J, Lindqvist M. Suppression of ethanol-induced locomotor stimulation by GABA-like drugs Naunyn-Schmiedeberg's Archives of Pharmacology. 295: 203-209. PMID 1012342 DOI: 10.1007/BF00505087  0.76
1976 Kehr W, Lindqvist M, Carlsson A. Distribution of Dopamine in the rat cerebral cortex Journal of Neural Transmission. 38: 173-180. PMID 956808 DOI: 10.1007/Bf01249437  0.353
1976 Almgren O, Snider SR, Carlsson A. Recovery of dopamine in peripheral adrenergic nerves after reserpine treatment Naunyn-Schmiedebergs Archives of Pharmacology. 292: 133-136. PMID 940594 DOI: 10.1007/Bf00498583  0.417
1976 Wålinder J, Skott A, Carlsson A, Roos B. Potentiation by Metyrosine of Thioridazine Effects in Chronic Schizophrenics: A Long-Term Trial Using Double-Blind Crossover Technique Archives of General Psychiatry. 33: 501-505. PMID 779704 DOI: 10.1001/Archpsyc.1976.01770040061011  0.31
1976 Magnusson T, Carlsson A, Fisher GH, Chang D, Folkers K. Effect of synthetic substance P on monoaminergic mechanisms in brain. Journal of Neural Transmission. 38: 89-93. PMID 5576 DOI: 10.1007/Bf01262967  0.591
1975 Ahlenius S, Carlsson A, Engel J. Antagonism by baclophen of the d-amphetamine-induced disruption of a successive discrimination in the rat. Journal of Neural Transmission. 36: 327-333. PMID 1165490 DOI: 10.1007/Bf01253132  0.549
1975 Lindqvist M, Kehr W, Carlsson A. Attempts to measure endogenous levels of dopa and 5-hydroxytryptophan in rat brain. Journal of Neural Transmission. 36: 161-176. PMID 1080799 DOI: 10.1007/Bf01253123  0.327
1975 Brown RM, Kehr W, Carlsson A. Functional and biochemical aspects of catecholamine metabolism in brain under hypoxia. Brain Research. 85: 491-509. PMID 236073 DOI: 10.1016/0006-8993(75)90822-7  0.446
1975 Waldeck B, Snider SR, Brown R, Carlsson A. Studies on the synthesis and subcellular distribution of dopamine in the rat adrenal medulla Naunyn-Schmiedebergs Archives of Pharmacology. 287: 1-10. PMID 235101 DOI: 10.1007/Bf00632633  0.38
1974 Brown RM, Snider SR, Carlsson A. Changes in biogenic amine synthesis and turnover induced by hypoxia and/or foot shock stress II. The central nervous system Journal of Neural Transmission. 35: 293-305. PMID 4548084 DOI: 10.1007/Bf02205226  0.376
1974 Snider SR, Brown RM, Carlsson A. Changes in biogenic amine synthesis and turnover induced by hypoxia and/or foot shock stress I. The adrenal medulla Journal of Neural Transmission. 35: 283-291. PMID 4474359 DOI: 10.1007/Bf02205225  0.369
1974 Carlsson A, Lindqvist M, Kehr W. Postmortal accumulation of 3-methoxytyramine in brain. Naunyn-Schmiedebergs Archives of Pharmacology. 284: 365-372. PMID 4281061 DOI: 10.1007/Bf00504705  0.36
1974 Lindqvist M, Kehr W, Carlsson A. Effect of pentobarbitone and diethyl ether on the synthesis of monoamines in rat brain Naunyn-Schmiedebergs Archives of Pharmacology. 284: 263-277. PMID 4279353 DOI: 10.1007/Bf00500346  0.387
1974 Carlsson A, Engel J, Strömbom U, Svensson TH, Waldeck B. Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis. Naunyn-Schmiedeberg's Archives of Pharmacology. 283: 117-28. PMID 4278296 DOI: 10.1007/BF00501138  0.601
1973 Carlsson A, Magnusson T, Svensson TH, Waldeck B. Effect of ethanol on the metabolism of brain catecholamines. Psychopharmacologia. 30: 27-36. PMID 4735977 DOI: 10.1007/BF00422791  0.571
1973 Ahlenius S, Carlsson A, Engel J, Svensson T, dersten PS. Antagonism by alpha methyltyrosine of the ethanol-induced stimulation and euphoria in man Clinical Pharmacology & Therapeutics. 14: 586-591. PMID 4723267 DOI: 10.1002/Cpt1973144Part1586  0.447
1973 Davis JN, Carlsson A. Effect of hypoxia on tyrosine and tryptophan hydroxylation in unanaesthetized rat brain. Journal of Neurochemistry. 20: 913-5. PMID 4703804 DOI: 10.1111/j.1471-4159.1973.tb00055.x  0.449
1973 Davis JN, Carlsson A, MacMillan V, Siesjö BK. Brain tryptophan hydroxylation: dependence on arterial oxygen tension. Science (New York, N.Y.). 182: 72-4. PMID 4542339 DOI: 10.1126/Science.182.4107.72  0.483
1973 Carlsson A, Lindqvist M, Magnusson T, Atack C. Effect of acute transection on the synthesis and turnover of 5-HT in the rat spinal cord. Naunyn-Schmiedeberg's Archives of Pharmacology. 277: 1-12. PMID 4350468 DOI: 10.1007/BF00498780  0.536
1973 Davis JN, Carlsson A. The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain. Journal of Neurochemistry. 21: 783-90. PMID 4148239 DOI: 10.1111/j.1471-4159.1973.tb07522.x  0.446
1973 Carlsson A, Lindqvist M. In-vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain. Journal of Neural Transmission. 34: 79-91. PMID 4146642 DOI: 10.1007/Bf01244661  0.332
1973 Carlsson A, Roos BE, Wålinder J, Skott A. Further studies on the mechanism of antipsychotic action: potentiation by alpha-methyltyrosine of thioridazine effects in chronic schizophrenics. Journal of Neural Transmission. 34: 125-132. PMID 4146641 DOI: 10.1007/Bf01244665  0.308
1973 Carlsson A, Lindqvist M. Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo. Journal of Pharmacy and Pharmacology. 25: 437-440. PMID 4146580 DOI: 10.1111/J.2042-7158.1973.Tb09129.X  0.37
1973 Snider SR, Almgren O, Carlsson A. The occurrence and functional significance of dopamine in some peripheral adrenergic nerves of the rat. Naunyn-Schmiedebergs Archives of Pharmacology. 278: 1-12. PMID 4145469 DOI: 10.1007/Bf00501858  0.42
1973 Carlsson A, Snider SR, Almgren O. The neurogenic short-term control of catecholamine synthesis and release in the sympatho-adrenal systems, as reflected in the levels of endogenous dopamine and β-hydroxylated catecholamines Life Sciences. 13: 551-556. DOI: 10.1016/0024-3205(73)90244-0  0.408
1972 Carlsson A, Davis JN, Kehr W, Lindqvist M, Atack CV. Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Archives of Pharmacology. 275: 153-68. PMID 4404948 DOI: 10.1007/Bf00508904  0.555
1972 Kehr W, Carlsson A, Lindqvist M, Magnusson T, Atack C. Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. The Journal of Pharmacy and Pharmacology. 24: 744-7. PMID 4404084 DOI: 10.1111/J.2042-7158.1972.Tb09104.X  0.574
1972 Carlsson A, Engel J, Svensson TH. Inhibition of ethanol-induced excitation in mice and rats by α-methyl-p-tyrosine Psychopharmacology. 26: 307-312. PMID 4403706 DOI: 10.1007/Bf00422706  0.53
1972 Carlsson A, Bédard P, Lindqvist M, Magnusson T. The influence of nerve-impulse flow on the synthesis and metabolism of hydroxytryptamine. The Biochemical Journal. 128: 70P-71P. PMID 4344007 DOI: 10.1042/Bj1280070P  0.495
1972 Carlsson A, Lindqvist M. The effect of L-tryptophan and some psychotropic drugs on the formation of 5-hydroxytryptophan in the mouse brain in vivo Journal of Neural Transmission. 33: 23-43. PMID 4264576 DOI: 10.1007/Bf01244726  0.333
1972 Kehr W, Carlsson A, Lindqvist M. A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain. Naunyn-Schmiedebergs Archives of Pharmacology. 274: 273-280. PMID 4262782 DOI: 10.1007/Bf00501936  0.305
1972 Carlsson A, Waldeck B. Formation of dopamine from 3-methoxytyrosine. Fact or artifact? Naunyn-Schmiedebergs Archives of Pharmacology. 272: 441-446. PMID 4260264 DOI: 10.1007/Bf00501250  0.369
1972 Bergmark J, Carlsson A, Granerus AK, Jagenburg R, Magnusson T, Svanborg A. Decarboxylation of orally administered L-dopa in the human digestive tract. Naunyn-Schmiedeberg's Archives of Pharmacology. 272: 437-40. PMID 4260263 DOI: 10.1007/BF00501249  0.508
1972 Bédard P, Carlsson A, Lindqvist M. Effect of a transverse cerebral hemisection on 5-hydroxytryptamine metabolism in the rat brain Naunyn-Schmiedebergs Archives of Pharmacology. 272: 1-15. PMID 4257469 DOI: 10.1007/Bf00498790  0.335
1970 Andén NE, Carlsson A, Kerstell J, Magnusson T, Olsson R, Roos BE, Steen B, Steg G, Svanborg A, Thieme G, Werdinius B. Oral L-dopa treatment of parkinsonism. Acta Medica Scandinavica. 187: 247-55. PMID 4911257 DOI: 10.1111/J.0954-6820.1970.Tb02939.X  0.548
1969 Carlsson A, Jonason J, Lindqvist M. On the mechanism of 5-hydroxytryptamine release by thymoleptics. Journal of Pharmacy and Pharmacology. 21: 769-773. PMID 4390836 DOI: 10.1111/J.2042-7158.1969.Tb08167.X  0.313
1968 Carlsson A, Meisch J, Waldeck B. On the β-hydroxylation of (±)-α-methyldopamine in vivo European Journal of Pharmacology. 5: 85-92. PMID 5718522 DOI: 10.1016/0014-2999(68)90160-X  0.327
1968 Carlsson A, Lindqvist M, Waldeck B. Mechanism of release of α-methylated noradrenaline analogues by monoamine oxidase inhibitors European Journal of Pharmacology. 3: 34-39. PMID 5654667 DOI: 10.1016/0014-2999(68)90045-9  0.324
1967 Carlsson A, Lindqvist M. Metatyrosine as a tool for selective protection of catecholamine stores against reserpine European Journal of Pharmacology. 2: 187-192. PMID 5590341 DOI: 10.1016/0014-2999(67)90085-4  0.406
1967 Carlsson A, Fuxe K, Hökfelt T. Failure of dopamine to accumulate in central noradrenaline neurons after depletion with diethyldithiocarbamate. Journal of Pharmacy and Pharmacology. 19: 481-483. PMID 4382644 DOI: 10.1111/J.2042-7158.1967.Tb08116.X  0.343
1965 ANDEN NE, CARLSSON A, HILLARP NA, MAGNUSSON T. NORADRENALINE RELEASE BY NERVE STIMULATION OF THE SPINAL CORD. Life Sciences. 4: 129-32. PMID 14283073  0.447
1965 Trčka V, Carlsson A. Mediodespidine, hypotensive reserpoid without sedative effect II. Effect on monoamine levels in mouse organs Life Sciences. 4: 2263-2267. PMID 5880876 DOI: 10.1016/0024-3205(65)90247-X  0.386
1964 ANDEN NE, CARLSSON A, HILLARP NA, MAGNUSSON T. 5-HYDROXYTRYPTAMINE RELEASE BY NERVE STIMULATION OF THE SPINAL CORD. Life Sciences. 3: 473-8. PMID 14198489  0.442
1964 SEIDEN LS, CARLSSON A. BRAIN AND HEART CATECHOLAMINE LEVELS AFTER L-DOPA ADMINISTRATION IN RESERPINE TREATED MICE: CORRELATIONS WITH A CONDITIONED AVOIDANCE RESPONSE. Psychopharmacologia. 5: 178-81. PMID 14138753 DOI: 10.1007/BF00413240  0.498
1963 Andén N, Carlsson A, Waldeck B. Reserpine-Resistent Uptake Mechanisms Of Noradrenaline In Tissues. Life Sciences. 2: 889-894. PMID 14100218 DOI: 10.1016/0024-3205(63)90056-0  0.301
1963 CARLSSON A, MAGNUSSON T, ROSENGREN E. 5-HYDROXYTRYPTAMINE OF THE SPINAL CORD NORMALLY AND AFTER TRANSECTION. Experientia. 19: 359. PMID 14067768 DOI: 10.1007/BF02152316  0.589
1963 SEIDEN LS, CARLSSON A. TEMPORARY AND PARTIAL ANTAGONISM BY L-DOPA OF RESERPINE-INDUCED SUPPRESSION OF A CONDITIONED AVOIDANCE RESPONSE. Psychopharmacologia. 4: 418-23. PMID 14048562 DOI: 10.1007/BF00403346  0.49
1962 Carlsson A, Lindqvist M. In‐Vivo Decarboxylation of α‐Methyl DOPA and α‐Methyl Metatyrosine Acta Physiologica Scandinavica. 54: 87-94. PMID 13876658 DOI: 10.1111/J.1748-1716.1962.Tb02331.X  0.36
1962 CARLSSON A, HILLARP NA. Formation of phenolic acids in brain after administration of 3,4-dihydroxyphenylalanine. Acta Physiologica Scandinavica. 55: 95-100. PMID 13876655 DOI: 10.1111/j.1748-1716.1962.tb02422.x  0.343
1959 BERTLER A, CARLSSON A, ROSENGREN E. Fluorimetric method for differential estimation of the 3-O-methylated derivatives of adrenaline and noradrenaline (metanephrine and normetanephrine. Clinica Chimica Acta; International Journal of Clinical Chemistry. 4: 456-7. PMID 13663254 DOI: 10.1016/0009-8981(59)90120-2  0.675
1958 BERTLER A, CARLSSON A, ROSENGREN E. A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta Physiologica Scandinavica. 44: 273-92. PMID 13617023 DOI: 10.1111/j.1748-1716.1958.tb01627.x  0.686
1958 BERTLER A, CARLSSON A, LINDQVIST M, MAGNUSSON T. On the catehol amine in blood plasma after stimulation of the sympathoadrenal system. Experientia. 14: 184-5. PMID 13548132 DOI: 10.1007/Bf02158656  0.712
1958 CARLSSON A, LINDQVIST M, MAGNUSSON T, WALDECK B. On the presence of 3-hydroxytyramine in brain. Science (New York, N.Y.). 127: 471. PMID 13529006 DOI: 10.1126/Science.127.3296.471  0.523
1958 Bertler Å, Carlsson A, Lindqvist M, Magnusson T. On the catechol amine levels in blood plasma after stimulation of the sympathoadrenal system Experientia. 14: 232. DOI: 10.1007/BF02159107  0.443
1957 CARLSSON A, LINDQVIST M, MAGNUSSON T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature. 180: 1200. PMID 13483658 DOI: 10.1038/1801200A0  0.601
1957 SHORE PA, PLETSCHER A, TOMICH EG, CARLSSON A, KUNTZMAN R, BRODIE BB. Role of brain serotonin in reserpine action. Annals of the New York Academy of Sciences. 66: 609-15; discussion, . PMID 13425244 DOI: 10.1111/J.1749-6632.1957.Tb40751.X  0.456
1957 Carlsson A, Lindqvist M, Magnusson T. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists [16] Nature. 180: 1200. DOI: 10.1038/1801200a0  0.57
1956 Bertler �, Carlsson A, Rosengren E. Release by reserpine of catechol amines from rabbits' hearts Die Naturwissenschaften. 43: 521-521. DOI: 10.1007/BF00596980  0.473
1955 CARLSSON A, MAGNUSSON T. Failure to demonstrate antipyretic and analgesic properties of salicylamides. Acta Pharmacologica Et Toxicologica. 11: 248-53. PMID 13301772 DOI: 10.1111/J.1600-0773.1955.Tb00224.X  0.471
1954 Carlsson A, Lindqvist M, Magnusson T. The influence of vitamin D on the uptake of S35-labelled sulfate in the bones. Acta Physiologica Scandinavica. 31: 312-316. PMID 13197103 DOI: 10.1111/J.1748-1716.1954.Tb01143.X  0.479
Show low-probability matches.